Feeley, Linda P <br/><br/>
Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information.  [electronic resource] 

 -  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc  Apr 2014 
 - 554-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-0285 
<br/><br/><label>Standard No.: </label>10.1038/modpathol.2013.153  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--chemistry<br/>Carcinoma--chemistry<br/>Chi-Square Distribution<br/>Diagnosis, Differential<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Ki-67 Antigen--analysis<br/>Multivariate Analysis<br/>Neoplasm Invasiveness<br/>Ontario<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Receptor, ErbB-2--analysis<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>Risk Factors<br/>Time Factors<br/>Tumor Suppressor Protein p53--analysis